Form 4: Schrodinger Director Arun Oberoi Reports Stock and Option Grants
SEC Form 4 Filing
Director Arun Oberoi reports the acquisition of restricted stock units and stock options in Schrodinger, Inc.
Summary
- Arun Oberoi, a director of Schrodinger, Inc., filed a Form 4 detailing changes in beneficial ownership.
- On June 18, 2024, Oberoi was granted 5,000 restricted stock units (RSUs) and an option to purchase 8,550 shares of common stock.
- The RSUs vest on the twelve-month anniversary of the grant date or the next annual meeting, subject to continued service.
- The stock options have an exercise price of $19.32 and also vest on the twelve-month anniversary of the grant date or the next annual meeting, subject to continued service.
- Following these transactions, Oberoi beneficially owns 11,250 shares of common stock, including 5,000 unvested RSUs, and options to purchase 8,550 shares.
Sentiment
Score: 7
Explanation: The document reflects standard executive compensation practices, indicating stability and alignment of interests. The grants are a positive sign of incentivizing key personnel.
Positives
- The grant of RSUs and stock options to a director aligns their interests with those of the shareholders.
- The vesting schedule encourages continued service and commitment to the company.
Future Outlook
The vesting of the RSUs and stock options is contingent upon continued service, suggesting an expectation of Oberoi's continued involvement with the company.
Industry Context
Grants of stock options and RSUs are common practices in the technology and pharmaceutical industries to incentivize and retain key personnel.
Comparison to Industry Standards
- Stock option grants to directors are a standard practice across publicly traded companies, particularly in the tech and biotech sectors, to align their interests with shareholder value.
- Companies like Relay Therapeutics, Recursion Pharmaceuticals, and Exscientia also utilize equity-based compensation for their board members.
- The vesting schedules, typically one year or aligned with annual meetings, are consistent with industry norms to ensure continued service and commitment.
Stakeholder Impact
- The grants of RSUs and stock options align the director's interests with those of the shareholders, potentially leading to decisions that increase shareholder value.
- Continued service requirement for vesting ensures stability and commitment from the director.
Key Dates
| Date | Description |
|---|---|
| 06/18/2024 | Date of transaction: Grant of restricted stock units and stock options. |
| 06/18/2034 | Expiration date of the stock options. |
| 06/20/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.